Clinical trialNCT02369159CompletedPhase 3Interventional

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

SponsorBioCryst PharmaceuticalsEnrollment137Influenza

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

John Vanchiere, MD, PhD
Chief, Pediatric Infectious Diseases, Louisiana State University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Africa

Peramivir Investigative Site
Pretoria, South Africa

United States

Peramivir Investigative Site
Shreveport, Louisiana, United States
Peramivir Investigative Site
Dayton, Ohio, United States
Peramivir Investigative Site
Smithfield, Pennsylvania, United States
Peramivir Investigative Site
Houston, Texas, United States
Peramivir Investigative Site
San Antonio, Texas, United States
Peramivir Investigative Site
Splendora, Texas, United States
Peramivir Investigative Site
Draper, Utah, United States
Peramivir Investigative Site
Salt Lake City, Utah, United States
Peramivir Investigative Site
South Jordan, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Oseltamivir →Peramivir

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Mar 2015
Primary completion: 28 Oct 2019
Completion: 14 May 2020
Last update posted: 23 Mar 2021
Registered enrollment: 137
Registry id: NCT02369159

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.